| New from NCI |
| Deaths from Cancer Continue to Decline |
 | | The 2019 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline and new cancer cases dropped in men and remained stable in women. A special section covers recent cancer trends in younger adults. |
| T-DM1 Approval Expanded for HER2-Positive Breast Cancer |
 | | The Food and Drug Administration has expanded the approved use of the targeted therapy ado-trastuzumab emtansine (Kadcyla), also called T-DM1, for some women after surgery for early-stage HER2-positive breast cancer. |
Studying Genes and Proteins Together Sheds New Light on Colon Cancer
Using novel proteogenomic techniques, which combine the study of genes and proteins, NCI scientists have uncovered new features of colon cancer that may guide new treatment strategies. |
Radiation for Controlling Pain from Bone Metastases
Read about the results from a clinical trial that was designed to find the best dose of radiation to treat pain from cancer that spread to the bone and whether a single dose was as effective as many lower doses delivered over 2 weeks. |
Rates of Aggressive Uterine Cancer Subtypes Rising
New findings from a study by NCI researchers show that the number of new cases of aggressive subtypes of uterine cancer in the U.S. rose rapidly during a 15-year study period. Learn more about the subtypes and the racial differences uncovered by the scientists.
|
| PDQ Cancer Information Summary Updates |
Nasopharyngeal Cancer Treatment
We’ve revised our PDQ summary on nasopharyngeal cancer with updated information on factors that affect prognosis (chance of recovery) and treatment options. |
No comments:
Post a Comment